e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Athanassa Z., Siempos I. I., Falagas M. E.
Source:
Eur Respir J 2008; 31: 625-632
Journal Issue:
March
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Athanassa Z., Siempos I. I., Falagas M. E.. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 2008; 31: 625-632
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Source: Eur Respir J 2006; 27: 1010-1019
Year: 2006
VAP: approach to therapy
Source: Eur Respir Mon 2011; 53: 36-47
Year: 2011
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008
S. pneumoniae
community-acquired pneumonia (SP-CAP): relationship between mortality and antibiotic susceptibility and risk factors for drug resistance
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant
staphylococcus aureus
(CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
Source: Eur Respir J 2002; 20: 432-439
Year: 2002
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial
Source: Eur Respir J 2004; 23: 921-926
Year: 2004
Antibiotic resistance and nosocomial pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005
Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007
MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009
New antibiotics for VAP
Source: Eur Respir Mon 2011; 53: 48-53
Year: 2011
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Source: Eur Respir J 2002; 20: 3S-8S
Year: 2002
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP)
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept